No Data
No Data
NeuroSense Therapeutics Reports Key Progress and Financials
NeuroSense Therapeutics Regains Compliance With Nasdaq Equity Requirement
Express News | Neurosense Regains Compliance With Nasdaq's Minimum Equity Requirement
Neurosense Therapeutics Files for Resale of Up to 5.28 Million Shares
NeuroSense Signs Term Sheet for Phase 3 PrimeC Trial in Amyotrophic Lateral Sclerosis
Express News | Neurosense Therapeutics Ltd: Co Would Retain Full Rights to Primec in Other Key Territories
No Data
Carlos Moreno138 : j8 on vrax, no cash on had what do you mien with that?
Jaguar8 OP Carlos Moreno138 : They don’t have cash to operate on
Carlos Moreno138 : so they are probably going to diluted
原来是你啊 : I don't understand why. $Intelligent Protection Managem (IPM.US)$ No volume.
Jaguar8 OP Carlos Moreno138 : Yes but they pump before dilution. That is what is happening for most stocks. Why? Because it adds cushion for it before it plummets to still satisfy price bid requirement
View more comments...